Sign In
Pharma
Lupin gets $25-mn fund
Industry
Lupin unveils injection for thiamine in US
Indian pharma sector set for 'volume to value leadership' journey in 2023
Lupin inks pact with Alvion to market drugs in Southeast Asia
Lupin gets USFDA nod for generic product, Sildenafil
Lupin receives tentative USFDA nod for Azilsartan Medoxomil tablets
Lupin launches diagnostics biz
Lupin, TB Alliance join hands for new therapy for drug-resistant Tuberculosis
USFDA issues warning letter on Lupin's Somerset facility, cites repeated violations at company's manufacturing facilities
Markets
Lupin introduces digital educator platform for asthma patients
Lupin change gears to bring Covid-19 drugs in market; approaches Gilead for Remdesivir
